Alpha 2.0
Login Register
» Articles » PMID: 5091160

Evidence for Inhibition of the Reuptake of 5-hydroxytryptamine and Noradrenaline by Tetrahydronaphthylamine in Rat Brain

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1971 Jun 1
PMID 5091160
Citations 5
Authors
J BRUINVELS
Affiliations
Soon will be listed here.
Abstract

1. The concentrations of 5-hydroxytryptamine (5-HT), 5-hydroxyindolacetic acid (5-HIAA) and noradrenaline (NA) in homogenized rat brains were determined after intraperitoneal injection of 1,2,3,4-tetrahydro-2-naphthylamine (THN).2. THN caused a decrease in the concentration of brain 5-HIAA without altering its 5-HT content, but the percentage of ;free 5-HT' in the supernatant increased. The decrease in 5-HIAA and the increase in free 5-HT were negatively correlated, suggesting inhibition of the reuptake of 5-HT.3. THN decreased brain NA content without changing free NA. The fact that no increase in free NA occurred is ascribed to the action of catechol-O-methyl-transferase.4. Inhibition of the reuptake of NA and of 5-HT was further studied by using the compounds 5-methyl-alpha-ethyl-meta-tyramine (H 75/12) and 4,alpha-dimethyl-meta-tyramine (H 77/77). The results of these studies also suggested inhibition by THN of the reuptake of 5-HT as well as of NA.5. The action of THN is explained by inhibition of the reuptake of NA and of 5-HT and by release of NA from its stores. However, the possibility is not excluded that, instead of releasing NA from its stores, THN inhibits the enzyme dopamine-beta-hydroxylase.

Citing Articles

Effects of benzoctamine and chlordiazepoxide on turnover and uptake of 5-hydroxytryptamine in the brain.

Lippmann W, Pugsley T Br J Pharmacol. 1974; 51(4):571-5.

PMID: 4480288 PMC: 1778070. DOI: 10.1111/j.1476-5381.1974.tb09676.x.

Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.

Pawlowski L, Nowak G, GORKA Z, Mazela H Psychopharmacology (Berl). 1985; 86(1-2):156-63.

PMID: 3927352 DOI: 10.1007/BF00431702.

Effects of tandamine and pirandamine, new potential antidepressants, on the brain uptake of norepinephrine and 5-hydroxytryptamine and related activities.

Pugsley T, Lippmann W Psychopharmacology (Berl). 1976; 47(1):33-41.

PMID: 1085452 DOI: 10.1007/BF00428698.

Effect of acute and chronic treatment of tandamine, a new heterocyclic antidepressant, on biogenic amine metabolism and related activities.

Pugsley T, Lippmann W Naunyn Schmiedebergs Arch Pharmacol. 1979; 308(3):239-47.

PMID: 503251 DOI: 10.1007/BF00501388.

Effects of 1-alkyl-1,2,3,4-tetrahydrocarbazole-1-ethanamines and related compounds, potential antidepressants, on biogenic amine uptake mechanisms.

Puglsey T, Lippmann W Experientia. 1977; 33(1):57-9.

PMID: 299847 DOI: 10.1007/BF01936753.

References
1.
UDENFRIEND S, ZALTZMAN-NIRENBERG P, Gordon R, Spector S . Evaluation of the biochemical effects produced in vivo by inhibitors of the three enzymes involved in norepinephrine biosynthesis. Mol Pharmacol. 1966; 2(2):95-105. View
2.
SHARMAN D . Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs. Br J Pharmacol Chemother. 1966; 28(2):153-63. PMC: 1510867. DOI: 10.1111/j.1476-5381.1966.tb01881.x. View
3.
Robinson D, SHARMAN D . The action of 2-amino-tetralin (beta-tetrahydronaphthylamine) on the metabolism of 5-hydroxytryptamine in the brain of the mouse. Br J Pharmacol Chemother. 1967; 29(3):335-41. PMC: 1557208. DOI: 10.1111/j.1476-5381.1967.tb01965.x. View
4.
Carlsson A, CORRODI H, Fuxe K, Hokfelt T . Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol. 1969; 5(4):357-66. DOI: 10.1016/0014-2999(69)90113-7. View
5.
Carlsson A, CORRODI H, Fuxe K, Hokfelt T . Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol. 1969; 5(4):367-73. DOI: 10.1016/0014-2999(69)90114-9. View